$71.01 -0.56 (-0.78%) Gilead Sciences Inc - NASDAQ

Jan. 20, 2017 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 71.01
Trade Time: Jan 20 04:00 PM Eastern Daylight Time
Change: -0.56 (-0.78%)
Prev Close: 71.57
Open: 71.97
Bid: 71.00
Ask: 71.01
  1. Gilead Will Boost HIV, NASH Drugs Amid Hep C Slump; Stock On 2-Week Dip

    Investors Business Daily | Jan. 20, 2017 | 15:02PM EST
  2. Incyte Poised To Outperform Biotech Industry On Strong Pipeline

    Investors Business Daily | Jan. 20, 2017 | 11:00AM EST
  3. Gilead, Merck, Alexion 2017 Views Hazy; Biogen May Surge: Analyst

    Investors Business Daily | Jan. 19, 2017 | 16:41PM EST
  4. Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

    Investors Business Daily | Jan. 18, 2017 | 16:33PM EST
  5. Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target

    TalkMarkets | Jan. 9, 2017 | 07:51AM EST
  6. Widespread Buying

    TalkMarkets | Jan. 6, 2017 | 15:46PM EST
  7. 5 Companies For Enterprising Investors Near 52 Week Lows – January 2017

    TalkMarkets | Jan. 4, 2017 | 18:01PM EST
  8. 10 Low PE Stock Picks For The Enterprising Investor – January 2017

    TalkMarkets | Jan. 3, 2017 | 11:33AM EST
  9. 10 Low PE Stock Picks For The Enterprising Investor

    TalkMarkets | Jan. 3, 2017 | 11:33AM EST
  10. Gilead Is A Hail Mary: 3 Better Stocks To Consider

    TalkMarkets | Dec. 23, 2016 | 12:21PM EST
  11. 10 Undervalued Stocks for the Enterprising Investor – December 2016

    TalkMarkets | Dec. 22, 2016 | 12:00PM EST
  12. 10 Undervalued Stocks for the Enterprising Investor

    TalkMarkets | Dec. 22, 2016 | 12:00PM EST
  13. Conatus Soars On Novartis Deal, Early FDA Nod For Clovis Drug

    TalkMarkets | Dec. 21, 2016 | 10:55AM EST
  14. Gilead Buying Alexion Tops Piper's Potential Events In 2017

    TalkMarkets | Dec. 21, 2016 | 08:36AM EST
  15. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets | Dec. 19, 2016 | 20:51PM EST
Trading Center